328 related articles for article (PubMed ID: 25458785)
1. Quinoline: a promising antitubercular target.
Keri RS; Patil SA
Biomed Pharmacother; 2014 Oct; 68(8):1161-75. PubMed ID: 25458785
[TBL] [Abstract][Full Text] [Related]
2. Recent progress on pyrazole scaffold-based antimycobacterial agents.
Keri RS; Chand K; Ramakrishnappa T; Nagaraja BM
Arch Pharm (Weinheim); 2015 May; 348(5):299-314. PubMed ID: 25820461
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Triazole: A Promising Antitubercular Agent.
Keri RS; Patil SA; Budagumpi S; Nagaraja BM
Chem Biol Drug Des; 2015 Oct; 86(4):410-23. PubMed ID: 25643871
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
8. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
[TBL] [Abstract][Full Text] [Related]
9. Quinoline and quinolones: promising scaffolds for future antimycobacterial agents.
Singh S; Kaur G; Mangla V; Gupta MK
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):492-504. PubMed ID: 25032745
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
[TBL] [Abstract][Full Text] [Related]
11. Antituberculosis drug research: a critical overview.
Beena ; Rawat DS
Med Res Rev; 2013 Jul; 33(4):693-764. PubMed ID: 22622957
[TBL] [Abstract][Full Text] [Related]
12. The magic bullets and tuberculosis drug targets.
Zhang Y
Annu Rev Pharmacol Toxicol; 2005; 45():529-64. PubMed ID: 15822188
[TBL] [Abstract][Full Text] [Related]
13. Identification of benzofuro[2,3-b]quinoline derivatives as a new class of antituberculosis agents.
Yang CL; Tseng CH; Chen YL; Lu CM; Kao CL; Wu MH; Tzeng CC
Eur J Med Chem; 2010 Feb; 45(2):602-7. PubMed ID: 19926361
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the research of heterocyclic compounds as antitubercular agents.
Yan M; Ma S
ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone derivatives and their anti-tubercular activities.
Fan YL; Wu JB; Cheng XW; Zhang FZ; Feng LS
Eur J Med Chem; 2018 Feb; 146():554-563. PubMed ID: 29407980
[TBL] [Abstract][Full Text] [Related]
19. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
20. New tuberculosis drugs on the horizon.
Cole ST; Riccardi G
Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]